Literature DB >> 8202711

Anergic T cells as suppressor cells in vitro.

G Lombardi1, S Sidhu, R Batchelor, R Lechler.   

Abstract

T cell-mediated suppression is an established phenomenon, but its underlying mechanisms are obscure. An in vitro system was used to test the possibility that anergic T cells can act as specific suppressor cells. Anergic human T cells caused inhibition of antigen-specific and allospecific T cell proliferation. In order for the inhibition to occur, the anergic T cells had to be specific for the same antigen-presenting cells (APCs) as the T cells that were suppressed. The mechanism of this suppression appears to be competition for the APC surface and for locally produced interleukin-2.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8202711     DOI: 10.1126/science.8202711

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  59 in total

1.  Competition for antigenic sites during T cell proliferation: a mathematical interpretation of in vitro data.

Authors:  J A Borghans; L S Taams; M H Wauben; R J de Boer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

Review 2.  Dominant regulation: a common mechanism of monoclonal antibody induced tolerance?

Authors:  K Honey; S P Cobbold; H Waldmann
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 3.  The contributions of T-cell anergy to peripheral T-cell tolerance.

Authors:  R Lechler; J G Chai; F Marelli-Berg; G Lombardi
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

4.  Induction of T cell anergy by liposomes with incorporated major histocompatibility complex (MHC) II/peptide complexes.

Authors:  A J van Rensen; L S Taams; M C Grosfeld-Stulemeyer; W van Eden; D J Crommelin; M H Wauben
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

Review 5.  Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function.

Authors:  A O Tzianabos
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

6.  Carcinogen-modified dendritic cells induce immunosuppression by incomplete T-cell activation resulting from impaired antigen uptake and reduced CD86 expression.

Authors:  G M Woods; K V Doherty; R C Malley; M J Rist; H K Muller
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

7.  Notch ligation by Delta1 inhibits peripheral immune responses to transplantation antigens by a CD8+ cell-dependent mechanism.

Authors:  Kenneth K Wong; Matthew J Carpenter; Lesley L Young; Susan J Walker; Grahame McKenzie; Alyson J Rust; George Ward; Laura Packwood; Karen Wahl; Luc Delriviere; Gerard Hoyne; Paul Gibbs; Brian R Champion; Jonathan R Lamb; Margaret J Dallman
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 8.  The peripheral generation of CD4+ CD25+ regulatory T cells.

Authors:  Arne N Akbar; Leonie S Taams; Mike Salmon; Milica Vukmanovic-Stejic
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

9.  Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion.

Authors:  Santiago Zelenay; Thiago Lopes-Carvalho; Iris Caramalho; Maria Francisca Moraes-Fontes; Manuel Rebelo; Jocelyne Demengeot
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

10.  Identification and characterization of a major tolerogenic T-cell epitope of type II collagen that suppresses arthritis in B10.RIII mice.

Authors:  H Miyahara; L K Myers; E F Rosloniec; D D Brand; J M Seyer; J M Stuart; A H Kang
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.